NOVEL ISOTHIAZOLE AND ISOXAZOLE COMPOUNDS AS TRANSFORMING GROWTH FACTOR (TGF) INHIBITORS

Details for Australian Patent Application No. 2003263431 (hide)

Owner PFIZER PRODUCTS INC.

Inventors Munchhof, Michael John; Blumberg, Laura Cook

Agent Spruson & Ferguson

Pub. Number AU-A-2003263431

PCT Number PCT/IB03/04005

PCT Pub. Number WO2004/026865

Priority 60/484,580 02.07.03 US; 60/412,131 18.09.02 US

Filing date 12 September 2003

Wipo publication date 8 April 2004

International Classifications

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/437

A61P 035/00 Antineoplastic agents

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 031/4709 - Non-condensed quinolines containing further heterocyclic rings

Event Publications

11 December 2003 Complete Application Filed

  Priority application(s): 60/484,580 02.07.03 US; 60/412,131 18.09.02 US

20 May 2004 Application Open to Public Inspection

  Published as AU-A-2003263431

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003263432-HYBRID CARD

2003263430-PROGESTERONE RECEPTOR ANTAGONISTS FOR REDUCING INCIDENCE OF STILLBORN PIGS